صحيفة روافد العربية ننقل الحدث كما حدث
HPV testing for detail sensors and danger stratification
The Aptima HPV test and Aptima HPV 16 18/45 genotype test goal HPV varieties that present the most significant risk to female. 2,3 While various other HPV assays desired DNA, the Aptima HPV assays focus mRNA, which studies also show echoes the appeal and sports of risky HPV problems. 2,3 The Aptima HPV report recognizes E6/E7 mRNA, which is an indication of those HPV attacks very likely to trigger cervical infection. 2 The Aptima HPV 16 18/45 genotype test identifies HPV varieties 16, 18 and 45, that connected with around 80per cent off unpleasant cervical cancers global. 3,15-16
Assessment females with Aptima HPV assays enable companies boost care for each patient.
The ThinPrep technique will help improve clinical workflow
The ThinPrep Pap challenge is among one of a few choices from inside the ThinPrep method. The ThinPrep processors, imagers and overview scopes help improve workflow in research laboratory and help with cytotechnologistsa€™ capacity to diagnose irregularities. These instruments allow completed the ThinPrep process and increase clinical ability and clarity in diseases recognition.
Besides the ThinPrep Pap taste, Hologic is still dedicated to supplying laboratories with innovative and successful cytology alternatives for non-gynecological screening requires.
From Pap and HPV assessments to our full range of symptomatic services cross-divisional creation for example the prodigy 3D Mammography exam for bust health, Hologic offers for females. The guarantee to offer you creative goods in order to satisfy the needs of people internationally persists throughout everything we manage, most notably in cervical diseases screening. Collaborating, we are able to obtain the goal of whipping cervical illness.
a diverse approach for womena€™s all natural medical
To understand more about the Aptima + ThinPrep Cervical Health portfolio, pay a visit to HealthDxS.
* Aptima HPV substance, Aptima HPV 16 18/45 Genotype substance, Cervista HPV HR experience, Cervista HPV 16/18 test, Roche cobas HPV make sure cross Capture 2 HPV DNA experience.
References: 1. ThinPrep 2000 Processor [instructions for use]. MAN-02624-001, Rev. 005. Marlborough, MA: Hologic, Inc.; 2017. 2. Aptima HPV analyze [package insert]. AW-12820-001, Rev. 001. Hillcrest, CA: Hologic, Inc.; 2015. 3. Aptima HPV Genotype 16 18/45 analyze [package insert]. AW-12821-001, Rev. 001. Hillcrest, CA: Hologic, Inc.; 2015. 4. Blatt AJ, et al. Evaluation of cervical malignant tumors evaluating results among 256,648 women in several medical procedures. Cancer Cytopathol. 2015;123(5):282-288 [Study included ThinPrep, SurePath, crossbreed get 2 assay]. 5. Saslow D, et al. United states Cancer Our society, United states environment for Colposcopy and Cervical Pathology, and United states culture for medical Pathology screening guidelines towards reduction and very early recognition of cervical cancers. CA Cancer J Clin. 2012; 62(3):147-172. 6. The United States School of Obstetricians and Gynecologists. Rehearse publication 168: Screening for cervical cancer tumors. Obstet Gynecol. 2016;128(4):3111-30. doi:10.1097/ AOG.0000000000001708. 7. stores for illness Control and avoidance. Cervical Disease is Avoidable. s://www.cdc.gov/vitalsigns/cervical-cancer/index.html. Upgraded November 5, 2014. Utilized December 29, 2017. 8. Domestic Cancer Tumors Institute. SEER Stat Fact Blankets: Cervix Uteri Disease. ://seer.cancer.gov/statfacts/html/cervix.html. Published 2016. Utilized December 4, 2017. 9. Nationwide Institutes of Health. NIH Reality Sheets: Cervical Malignant Tumors. ://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=76. Current March 29, 2013. Accessed November 29, 2017. 10. Hologic, Inc. Data on File. 11. Hologic, Inc. See Printed Reports: Direct-to-Vial Research. s://healthdxs/en/view-published-data/ 
. Accessed December 29, 2017. 12. Eversole GM, ainsi, al. Procedures of people inside university of American Pathologists interlaboratory evaluation regimen in cervicovaginal cytology, 2006. Posture Pathol Laboratory Med. 2010;134(3):331-5. doi:10.1043/1543-2165-134.3.331. 13. Adegoke O, ainsi, al. Cervical Cancer styles in the United States: A 35-Year Population-Based testing. J Females Overall Health. 2012;21(10):1031-1037. 14. PrepStain Method [product insert]. 779-07085-00, Rev. F. Burlington, NC: TriPath Imaging, Inc., 2011. 15. Li N, ainsi, al. Individual papillomavirus kinds submission in 30,848 intrusive cervical varieties of cancer globally: version by physical domain, histological form and season of book. Int J Cancer. 128:927-935. doi:10.1002/ijc.25396. 16. De Sanjose S, ainsi, al. 2010. Real papillomavirus genotype attribution in intrusive cervical cancer: a retrospective cross-sectional globally research. Lancet. doi:10.1016/S1470-2045(10)70230-8.
Info given with this bill is intended for visitors beyond your U . S .. Consult with “USA” bill for products and states on the usa.
